|
Reliance Industries Limited
|
|
POLYPROPYLENE
|
| REPOL B250EG |
IMPACT COPOLYMER |
| |
| Product description &
applications : |
Features : |
|
REPOL Polypropylene B250EG is manufactured using Unipol
PP process which combines the production efficiency
of gas phase fluidized bed reactor technology with the
high activity and stereo specificity of the SHAC catalyst
system.
REPOL B250EG is recommended for use in Extrusion Coating
process where high flow strength is required. It is
an ideal material for coating of polypropylene woven
fabrics.
|
Repol
B250EG is designed to provide
- Excellent flow characteristics
- Consistent processability
- Good surface finish and gloss
|
| |
| Typical properties of Repol
B250EG are as follows: |
| |
| Property |
ASTM Test Method |
Unit |
Typical Value*. |
| Melt flow index,(230oc/2.16Kg) |
D 1238 |
g/10 min |
25.0 |
| Tensile Strength at yield
(50 mm/min ) |
D 638$ |
MPa |
24 |
| Elongation at yield (50
mm/min ) |
D 638$ |
% |
6 |
| Flexural modulus (1% secant) |
D 790A$ |
MPa |
900 |
| Notched izod impact strength
(23oc) |
D 256$ |
J/m |
50 |
| Heat deflection temperature
(455 kPa) |
D 648 |
oC |
95 |
| |
|
$ : ASTM D638 Type I specimen injection moulded and
tested in accordance with ASTM D4101.
|
|
|
|
Repol B250EG meets the requirements stipulated in IS
10910-1984 on on "Specification for Polypropylene and
its copolymers for safe use in contact with foodstuffs,
pharmaceuticals, and drinking water". Additives incorporated
in this grade conform to the positive list of constituents
as prescribed in IS-10909-1984.The grade and the additives
incorporated in it also comply with the FDA:CFR Title
21, 177.1520, Olefin polymers.
|
|
|
|
REPOL is the registered trademark for Polypropylene
from Reliance Industries Limited
|
|
|
|
* Typical values with injection moulded specimens,
not to be taken as specification
|
|
The data, information and suggestions contained contained
herein are given purely as a guide. Reliance Industries
Limited and Reliance Group Companies undertake no responsibility
either for the results deriving from their adoption
or for possible position in apparent contrast with existing
patent rights.
|